UK Generic Price Hikes Under Scrutiny, Monitoring Could Be In Store As Hunt Stays On At Health
Executive Summary
The UK Competition and Markets Authority is looking into claims that some generic prices have been raised excessively, while a proposal by health secretary Jeremy Hunt that such price hikes could be systematically monitored could well go ahead after he retained his post in the new prime minister's cabinet.
You may also be interested in...
Australia To Give Consumers More Formal Role In HTA Processes
The health department says consumers and patients should be able to initiate health technology assessments because many potentially helpful and lifesaving medicines might never be assessed for funding due to “a lack of commercial incentive for pharmaceutical companies.”
EC Defends Data Protection Cut As EU ‘Pharma Package’ Nears Crucial Milestone
Proposals to overhaul the general pharmaceutical legislation will ensure that the EU “continues to have one of the most generous systems of incentives in the world,” the European Commission says.
European Parliament Clears EU-Wide Compulsory Licensing Proposal
The draft regulation, which includes a ban on exports of drugs manufactured under an EU compulsory license, will be discussed with the EU member states after the June parliamentary elections.